Stayble Therapeutics Ab Stock Last Dividend Paid
| STABL Stock | SEK 0.49 0.02 4.26% |
Stayble Therapeutics AB fundamentals help investors to digest information that contributes to Stayble Therapeutics' financial success or failures. It also enables traders to predict the movement of Stayble Stock. The fundamental analysis module provides a way to measure Stayble Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stayble Therapeutics stock.
Stayble |
Stayble Therapeutics AB Company Last Dividend Paid Analysis
Stayble Therapeutics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Stayble Therapeutics AB has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Sweden stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Stayble Fundamentals
| Return On Equity | -0.76 | |||
| Return On Asset | -0.44 | |||
| Operating Margin | (97.37) % | |||
| Current Valuation | 15.2 M | |||
| Shares Outstanding | 13.85 M | |||
| Shares Owned By Insiders | 32.55 % | |||
| Shares Owned By Institutions | 22.10 % | |||
| Price To Book | 2.85 X | |||
| Price To Sales | 213.81 X | |||
| Gross Profit | 9 K | |||
| EBITDA | (12.03 M) | |||
| Net Income | (12.09 M) | |||
| Cash And Equivalents | 42.71 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 850 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 63.53 X | |||
| Book Value Per Share | 1.43 X | |||
| Cash Flow From Operations | (9.63 M) | |||
| Earnings Per Share | (1.27) X | |||
| Beta | 0.76 | |||
| Market Capitalization | 49.02 M | |||
| Total Asset | 43.64 M | |||
| Z Score | 34.2 | |||
| Net Asset | 43.64 M |
About Stayble Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stayble Therapeutics AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stayble Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stayble Therapeutics AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Stayble Stock Analysis
When running Stayble Therapeutics' price analysis, check to measure Stayble Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stayble Therapeutics is operating at the current time. Most of Stayble Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stayble Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stayble Therapeutics' price. Additionally, you may evaluate how the addition of Stayble Therapeutics to your portfolios can decrease your overall portfolio volatility.